Lanean...
Targeting Disseminated Estrogen-Receptor-Positive Breast Cancer Cells in Bone Marrow
Estrogen receptor-positive (ER+) breast cancer can recur up to 20 years after initial diagnosis. Delayed recurrences arise from disseminated tumors cells (DTCs) in sites such as bone marrow that remain quiescent during endocrine therapy and subsequently proliferate to produce clinically-detectable m...
Gorde:
| Argitaratua izan da: | Oncogene |
|---|---|
| Egile Nagusiak: | , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7442734/ https://ncbi.nlm.nih.gov/pubmed/32678295 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-020-01391-z |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|